Skip to content
PeptideAgent

How much does kisspeptin-10 cost?

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The short answer

Not covered; there is no approved or lawfully compounded product to cover.

Regulatory: Not eligible for compoundingVerified: Verified Sep 22, 2026
With insurance
Not published
Compounded pharmacy
Not published

What each price includes, with sources

What does kisspeptin-10 cost in each channel?

Prices in US dollars at the verification date. Ranges are published list or program prices where a primary source exists; notes say when a figure is a typical market range instead.

Kisspeptin-10 price by purchase channel
ChannelPrice (USD)Notes
With insuranceNot publishedNot covered. Medicare Part D and commercial pharmacy benefits cover FDA approved drugs for accepted indications; compounded or unapproved peptides are paid in cash. [2]
Compounded pharmacyNot publishedNo lawful compounded price. Kisspeptin-10 has been on the 503A Category 2 list since September 29, 2023 and remained there on the FDA page current to April 22, 2026, so 503A pharmacies may not compound it. [1]

What is the list price of kisspeptin-10?

There is no list price and no licensed channel outside clinical trials. Research chemical listings are not lawful for human use and are not verified for purity.

Does insurance cover kisspeptin-10?

Not covered; there is no approved or lawfully compounded product to cover.

What changes the price?

  • Category 2 listing, which bars compounding

Frequently asked questions

How much does kisspeptin-10 cost without insurance?

No lawful compounded price. Kisspeptin-10 has been on the 503A Category 2 list since September 29, 2023 and remained there on the FDA page current to April 22, 2026, so 503A pharmacies may not compound it. [1]

Does insurance cover kisspeptin-10?

Not covered; there is no approved or lawfully compounded product to cover. [2]

What is the list price of kisspeptin-10?

There is no list price and no licensed channel outside clinical trials. Research chemical listings are not lawful for human use and are not verified for purity.

Sources

  1. [1]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (Category 2 list and withdrawn nominations, content current as of April 22, 2026)FDA
  2. [2]Medicare.gov: prescription drug coverage (Part D and outpatient drugs)